HIF1A and familial pancreatic carcinoma: Recent studies reported that CsA might enhance the chemotherapeutic effect of cytotoxic agents in various cancers [20], [31], [32], [34], whereas HIF-1α knockdown might increase chemo-sensitivity in pancreatic cancer cell line [35].